基酸通过升调Nrf2/GPX4通路来抑制铁和改善良性前列腺增生症
Dayong Yang1, Chengxi Zhai1, Junyu Ren1
1Kunming Medical University Sixth Affiliated Hospital (Yuxi People's Hospital), Yuxi City, Yunnan Province, China.
World journal of urology
|May 20, 2025
概括
基酸 (HCA) 为良性前列腺增生 (BPH) 提供了一种新的治疗方法. 通过激活Nrf2/GPX4通路,HCA抑制铁亡,从而改善BPH症状.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 良性前列腺增生 (BPH) 是老年男性患有治疗选择有限的普遍疾病.
- BPH的发病过程涉及复杂的因素,包括铁,氧化应激和炎症.
- 基酸 (HCA) 具有抗ferroptosis,抗炎和抗氧化特性,但其在BPH中的作用尚未研究.
研究的目的:
- 研究HCA对BPH的治疗作用.
- 阐明HCA在BPH治疗中的潜在分子机制.
- 探索HCA作为BPH的潜在新疗法策略.
主要方法:
- 建立了一个 propionate (TP) 诱导的BPH小鼠模型.
- 用HCA治疗小鼠,评估前列腺指数,组织病理学和线粒体形态学.
- 分析了铁亡标记物 (Fe2+,MDA,GSH) 和Nrf2/GPX4蛋白表达.
主要成果:
- 受TP诱导的BPH小鼠显示铁亡标志物 (Fe2+,MDA) 升高,GSH和GPX4水平降低.
- HCA治疗显著降低了前列腺指数,并改善了他的病理变化.
- HCA上调了Nrf2和GPX4的表达,抑制了铁亡并没有对肝脏/脏功能产生不良影响.
结论:
- 通过抑制铁亡,HCA有效地改善TP诱导的BPH.
- Nrf2/GPX4通路对于HCA在BPH中的保护作用至关重要.
- HCA为BPH管理提出了一个有前途的新型治疗策略.
相关概念视频
Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K


